Neurocrine Biosciences
NBIX
#1447
Rank
S$16.03 B
Marketcap
$158.76
Share price
1.70%
Change (1 day)
3.90%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of June 2024 : S$3.26 B

According to Neurocrine Biosciences 's latest financial reports the company has S$3.26 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$S$2.94 B28.75%
2022-12-31$S$2.28 B23.56%
2021-12-31$S$1.85 B24.45%
2020-12-31$S$1.48 B73.84%
2019-12-31$S$0.85 B30.77%
2018-12-31$S$0.65 B31.58%
2017-12-31$S$0.49 B9.22%
2016-12-31$S$0.45 B-24.17%
2015-12-31$S$0.60 B117.93%
2014-12-31$S$0.27 B80.72%
2013-12-31$S$0.15 B-19.23%
2012-12-31$S$0.18 B142.78%
2011-12-31$S$77.8 M212.11%
2010-12-31$S$24.92 M348.66%
2009-12-31$S$5.55 M-89.49%
2008-12-31$S$52.88 M-69.19%
2007-12-31$S$0.17 B-64.44%
2006-12-31$S$0.48 B-25.7%
2005-12-31$S$0.64 B11.85%
2004-12-31$S$0.58 B-12.76%
2003-12-31$S$0.66 B71.07%
2002-12-31$S$0.38 B-32.28%
2001-12-31$S$0.57 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
S$2.58 B-20.84%๐Ÿ‡บ๐Ÿ‡ธ USA
S$12.70 B 288.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$2.05 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.76 B 443.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.88 B 171.84%๐Ÿ‡บ๐Ÿ‡ธ USA
S$114.59 B 3,406.10%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.62 B-80.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$47.41 M-101.45%๐Ÿ‡บ๐Ÿ‡ธ USA